FCCM
ENTA icon

First City Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

First City Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,150
Closed -$38K – 675
2015
Q4 		$38K Hold
1,150
– – 0.03% 316
2015
Q3 		$41.6K Buy
+1,150
New +$49.4K 0.03% 313

Other funds holding ENTA

ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First City Capital Management's ENTA Position: Q1 2016 in Review

First City Capital Management sold out of Enanta Pharmaceuticals (ENTA) in Q1 2016, closing a stake of 1,150 shares — an estimated $38K sold.

First City Capital Management first reported a position in ENTA in Q3 2015 and held it in 2 quarters. The position peaked at $41.6K in Q3 2015. 152 funds tracked by Wall St. Rank hold ENTA as of Q1 2016.

  • First City Capital Management reported no remaining Enanta Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • First City Capital Management sold 1,150 Enanta Pharmaceuticals shares in Q1 2016, an estimated $38K.
  • First City Capital Management first reported a position in Enanta Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • First City Capital Management's Enanta Pharmaceuticals position peaked at $41.6K in Q3 2015.
  • 152 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2016.

Based on First City Capital Management's 13F filing for Q1 2016, filed 12 May 2016.